Excellence in patient care and education is predicated on a strong commitment to advancing the understanding and treatment of the serious neurological disorders that we manage in our Division. Our faculty are nationally recognized physician-scientists in stroke and neurocritical care and hold multiple foundation, industry, and federally funded grants.
Many faculty members serve in leadership roles on national and international trials in stroke and neurocritical care. We are also one of 25 regional coordinating centers for the new NIH StrokeNet clinical trial network.
Learn more about our division’s clinical trials.
Our portfolio is quite diverse in depth and breadth and includes the following broad areas:
- Clinical trials comparing different treatments for interrupting acute stroke, preventing complications and recurrence, and improving neurological recovery.
- New strategies for detecting the origin of “stroke of unknown cause” and finding the best treatment for this vexing condition
- Studying the biology of arterial disease in the brain using advanced imaging techniques.
- Prospective outcomes research with sophisticated patient registries (Northwestern University Brain Attack Registry: NUBAR) designed to improve our protocols for care and quality of life for patients.
- Brain and systemic disease interactions that result in encephalopathy and long-term cognitive dysfunction after critical illness
- Circadian dysfunction and cognitive outcomes in critical illness
- Cerebral small vessel disease
- Vascular cognitive impairment
- Improving community engagement and reducing disparities in stroke care